De Vriese_2007_Endocrinology_148_2355

Reference

Title : Ghrelin interacts with human plasma lipoproteins - De Vriese_2007_Endocrinology_148_2355
Author(s) : De Vriese C , Hacquebard M , Gregoire F , Carpentier Y , Delporte C
Ref : Endocrinology , 148 :2355 , 2007
Abstract :

Ghrelin, a peptide hormone produced predominantly by the stomach, stimulates food intake and GH secretion. The Ser(3) residue of ghrelin is mainly modified by a n-octanoic acid. In the human bloodstream, ghrelin circulates in two forms: octanoylated and desacylated. We previously demonstrated that ghrelin is desoctanoylated in human serum by butyrylcholinesterase (EC 3.1.1.8) and other esterase(s), whereas in rat serum, only carboxylesterase (EC 3.1.1.1) is involved. The aims of this study were to determine the role of lipoprotein-associated enzymes in ghrelin desoctanoylation and the role of lipoproteins in the transport of circulating ghrelin. Our results show that ghrelin desoctanoylation mostly occurred in contact with low-density lipoproteins (LDLs) and lipoprotein-poor plasma subfractions. Butyrylcholinesterase and platelet-activating factor acetylhydrolase (EC 3.1.1.47) were responsible for the ghrelin hydrolytic activity of the lipoprotein-poor plasma and LDL subfractions, respectively. Moreover, we observed that ghrelin is associated with triglyceride-rich lipoproteins (TRLs), high-density lipoproteins (HDLs), very high-density lipoproteins (VHDLs), and to some extent LDLs. In conclusion, we report that the presence of the acyl group is necessary for ghrelin interaction with TRLs and LDLs but not HDLs and VHDLs. Ghrelin interacts via its N- and C-terminal parts with HDLs and VHDLs. This suggests that, whereas TRLs mostly transport acylated ghrelin, HDLs and VHDLs transport both ghrelin and des-acyl ghrelin.

PubMedSearch : De Vriese_2007_Endocrinology_148_2355
PubMedID: 17289852

Related information

Substrate Octanoyl-ghrelin

Citations formats

De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C (2007)
Ghrelin interacts with human plasma lipoproteins
Endocrinology 148 :2355

De Vriese C, Hacquebard M, Gregoire F, Carpentier Y, Delporte C (2007)
Endocrinology 148 :2355